Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rowe

Showing results (981-990 of 1,019) with videos related to

Pageof 102
Sort By:
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Autonomic Neuroscience : Basic & Clinical|July 11, 2021
Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2Satish R Raj, Kate M Bourne, Lauren E Stiles, et al.
Pageof 102

Showing results (981-990 of 1,019) with videos related to

Sort By:
Pageof 102
Nature Communications|November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's diseaseKevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's diseaseAlan Rembach, Noel G Faux, Andrew D Watt, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2018
Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohortsRachel F Buckley, Elizabeth C Mormino, Rebecca E Amariglio, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyQiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology|July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer diseaseJames D Doecke, Simon M Laws, Noel G Faux, et al.
Neurology|July 26, 2013
Impaired default network functional connectivity in autosomal dominant Alzheimer diseaseJasmeer P Chhatwal, Aaron P Schultz, Keith Johnson, et al.
Annals of Neurology|January 26, 2026
When Does Alzheimer's Disease Start? Plasma Aβ42/40 Assays Show Steep Changes at Aβ-PET Centiloid 15, Mean Age of 66 YearsRodrigo Cánovas, Timothy Cox, Vincent Doré, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of agingJames K Lui, Simon M Laws, Qiao-Xin Li, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Development, initial validation, and application of a visual read method for [<sup>18</sup>F]MK-6240 tau PETJoanna L Shuping, Dawn C Matthews, Katarzyna Adamczuk, et al.
Autonomic Neuroscience : Basic & Clinical|July 11, 2021
Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019 National Institutes of Health Expert Consensus Meeting - Part 2Satish R Raj, Kate M Bourne, Lauren E Stiles, et al.
Pageof 102